Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 269
Growth YoY: +12.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 251–300 of 5,037 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07833839	ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma	not yet recruiting	Phase 3	440	Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY	1	Sep 22, 2026	clinicaltrials
NCT07835087	Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer	recruiting	N/A	36	Beijing Friendship HospitalOTHER	1	Sep 22, 2026	clinicaltrials